Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

E. W. Alton, P. G. Middleton, N. J. Caplen, S. N. Smith, D. M. Steel, F. M. Munkonge, P. K. Jeffery, D. M. Geddes, S. L. Hart, R. Williamson, K. I. Fasold, A. D. Miller, P. Dickinson, B. J. Stevenson, McLachlan G., J. R. Dorin, D. J. Porteous

Research output: Contribution to journalArticlepeer-review

Abstract

We report gene transfer to the Edinburgh insertional mutant mouse (cf/cf), delivering CFTR cDNA-liposome complexes into the airways by nebulization. We show full restoration of cAMP related chloride responses in some animals and demonstrate, in the same tissues, human CFTR cDNA expression. Overall, a range of correction was seen with restoration of about 50% of the deficit between wild type mice and untreated cf/cf controls. We report modest correction in the intestinal tract following direct instillation and provide initial encouraging safety data for both the respiratory and intestinal tract following the liposome mediated gene delivery. The non-viral nature and potentially lower immunogenicity of DNA-liposomes suggest that this may offer a therapeutic alternative to adenoviral therapies.
Original languageEnglish
Pages (from-to)135-142
Number of pages8
JournalNature Genetics
Volume5
Issue number2
Publication statusPublished - 1993

Keywords

  • Animals Base Sequence Biological Transport/genetics Cystic Fibrosis/genetics/*therapy Cystic Fibrosis Transmembrane Conductance Regulator DNA, Complementary *Gene Therapy Genes, Reporter Humans Intestines Ions Liposomes Membrane Proteins/*genetics Mice Mice, Mutant Strains Molecular Sequence Data Nebulizers and Vaporizers Oligodeoxyribonucleotides

Fingerprint

Dive into the research topics of 'Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice'. Together they form a unique fingerprint.

Cite this